课题基金 / 基金详情

DEVELOPMENT OF POLYAMINE ANALOGS AS ANTICANCER AGENTS

DEVELOPMENT OF POLYAMINE ANALOGS AS ANTICANCER AGENTS
作为抗癌剂的聚胺类似物的开发
批准号:
3459331
负责人:
Hirak S. Basu
金额:
$8.69万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-01-01 至 1994-12-31

项目摘要

项目成果

Hirak S. Basu的其他基金

相关文献

中文摘要
翻译
拟议工作的目标是研究的影响
英文摘要
The objectives of the proposed work are to study the effect of the distribution of surface positive charges of polyamines on the interactions with nucleic acids and to use these results to design and synthesize polyamine analogs with modified charge distributions that may have different affinities for nucleic acids than the naturally-occurring polyamines. The analogs should physically replace natural polyamines without duplicating at least some of their biological functions. The specific aims are: 1) to measure the association constants of naturally-occurring polyamines and synthetic polyamine analogs with DNA and polynucleotides using Spectroscopic methods; 2) to determine whether polyamine analogs will mimic the condensation of DNA and/or the induction of the B to Z transition of specific polynucleotides caused by naturally-occurring polyamines; 3) to test the effects of specific analogs on the growth and viability of cultured human and rodent brain tumor cells; 4) to study the effects on the cytotoxicity of CENUs and Cis-Pt caused by replacement of naturally- occurring polyamines with effective analogs previously identified: and, 5) to assist the effects of analogs on DNA crosslinking caused by CENU and cis- Pt. Results obtained in Aims 1 and 2 will be used to choose and design effective analogs, and results from Aims 3-5 will allow evaluation of the effects of analogs on living cells that may lead to the design of therapeutically important anticancer agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
  • 批准号:
    8687192
  • 项目类别:
  • 资助金额:
    $75.13万
  • 财政年份:
    2014
  • 负责人:
    Hirak S. Basu
  • 依托单位:
Validation of Biomarkers to Distinguish Aggressive from Indolent Prostate Cancer
  • 批准号:
    8642164
  • 项目类别:
  • 资助金额:
    $16.13万
  • 财政年份:
    2013
  • 负责人:
    Hirak S. Basu
  • 依托单位:
Androgen Receptor-JunD Complex Inhibitors to Prevent Prostate Cancer Progression
  • 批准号:
    8315084
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2012
  • 负责人:
    Hirak S. Basu
  • 依托单位:
Mitochondria Targeted Anti-oxidant for Treatment of Prostate Cancer
  • 批准号:
    7483307
  • 项目类别:
  • 资助金额:
    $10.96万
  • 财政年份:
    2008
  • 负责人:
    Hirak S. Basu
  • 依托单位: